: Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.
Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System / Panebianco, V., Briganti, A., Boellaard, T.N., Catto, J., Comperat, E., Efstathiou, J., van der Heijden, A.G., Giannarini, G., Girometti, R., Mertens, L., Takeuchi, M., Muglia, V.F., Narumi, Y., Novara, G., Pecoraro, M., Roupret, M., Sanguedolce, F., Santini, D., Shariat, S.F., Simone, G., et al.. - In: NATURE REVIEWS. UROLOGY. - ISSN 1759-4812. - (2023). [10.1038/s41585-023-00830-2]
Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System
Panebianco, Valeria;Pecoraro, Martina;Santini, Daniele;
2023
Abstract
: Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.| File | Dimensione | Formato | |
|---|---|---|---|
|
nature.pdf
solo gestori archivio
Note: Panebianco_Clinical application of bladder MRI_2023
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.23 MB
Formato
Adobe PDF
|
1.23 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
